Elena Feinstein
Hoofd Techniek/Wetenschap/O&O bij Quark Pharmaceuticals, Inc.
Actieve functies van Elena Feinstein
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Hoofd Techniek/Wetenschap/O&O | 01-01-1998 | - |
Loopbaan van Elena Feinstein
Opleiding van Elena Feinstein
| Moscow University | Doctorate Degree |
| Weizmann Institute of Science | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 2 |
| Rusland | 2 |
| Israël | 2 |
Operationeel
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
- Beurs
- Insiders
- Elena Feinstein
- Ervaring
